# Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

> **NCT00073710** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 30 (—)

## Conditions studied

- Secondary Hyperparathyroidism
- Chronic Kidney Disease

## Interventions

- **DRUG:** Zemplar
- **PROCEDURE:** 42 Ca carbonate absorption via single tracer method
- **DRUG:** Calcijex

## Key facts

- **NCT ID:** NCT00073710
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073710, "Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00073710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*